E11.1_EBV_lytic_mechanisms.zip (1.51 GB)
Supporting data for “Mechanisms of Epstein-Barr virus (EBV) lytic cycle reactivation by a novel compound E11 intermediate (E11.1) in EBV-associated epithelial malignancies”
figureposted on 2021-11-22, 10:02 authored by . Mike-Dorothea. Mike-Dorothea
The dataset includes raw data and intermediate files generated in preparing the figures included in Mike Dorothea's thesis, entitled "Mechanisms of Epstein-Barr virus (EBV) lytic cycle reactivation by a novel compound E11 intermediate (E11.1) in EBV-associated epithelial malignancies". The data is organized according to the experimental technique used, subcategorized by the general experimental aim and arranged into folders depending on the cell line used and/or drug treatment time.
Effects on induction of viral lytic cycle in Epstein-Barr virus-associated epithelial malignancies by combining histone deacetylase inhibitor and a novel organic compound (17160712)
Epstein-Barr VirusEBVLytic cycleGastric carcinomaGCNasopharyngeal carcinomaNPCNovel compoundE11E11 intermediateE11.1JNK pathwayP38 MAPK signalingc-FOSc-JUNAP-1HDAC inhibitorsRomidepsinSuberanilohydroxamic acidApoptosis assayCell cycle assayEBV infection assayFlow cytometryWestern blotImmunofluorescence assayMTT assayROS assayDCFDACancerInfectious AgentsMedicineVirology